Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central nervous process, conolidine modulates alternate molecular targets. A Science Advancements review observed that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://trentonupwff.livebloggs.com/44829404/considerations-to-know-about-alternative-natural-pain-relief-to-replace-traditional-painkillers